Epitome Holdings Private Limited's Insider Trades & SAST Disclosures
Epitome Holdings Private Limited's most recent trade in Morepen Laboratories Ltd. was a Acquisition of 3,500,000 Equity Shares done at an average price of Rs. 25 . Disclosure was reported to the exchange on April 5, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Epitome Holdings Private Limited in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morepen Laboratories | Epitome Holdings Private Limited | Promoter Group | Acquisition | 05 Apr 2022 | 3,500,000 | 14,500,820 (3.04%) | 0.78% | 25 | 87,500,000 | 30 Mar 2022 30 Mar 2022 |
Insider Trading | Equity Shares | Conversion of security |
| Morepen Laboratories | Epitome Holdings Private Limited | Promoter Group | Acquisition | 01 Apr 2021 | 3,500,000 | 3,500,000 (0.72%) | 0.78% | 25 | 87,500,000 | 25 Mar 2021 25 Mar 2021 |
Insider Trading | Warrants | Preferential Offer |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.